PE
Peter Emtage
Chief Executive Officer at Santa Ana Bio
San Francisco Bay Area
Overview
Peter Emtage is the CEO of Santa Ana Bio, Inc., with a background in clinical development and biochemistry. He has held key roles in companies like Kite Pharma and Cell Design Labs, showcasing expertise in cell therapy research and biotechnology.
Emtage's career highlights include serving as the Global Head of Cell Therapy Research at Kite Pharma and Chief Scientific Officer at Cell Design Labs, demonstrating a strong track record in leading innovative research and development initiatives in the biotech industry.
Work Experience
Chief Executive Officer
2021 - Current
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Raised $176,024,658.00 from Andreessen Horowitz, RTW Investments, Access Biotechnology and Google Ventures.
Venture Partner
2020
Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Global Head of Cell Therapy Research
2018 - 2020
Chief Scientific Officer
2016 - 2018
Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases. Cell Design Labs leverages the power of the body’s immune system to develop smart, living therapies with the capability to treat our most challenging diseases with unprecedented power, precision, safety and durability.